UPDATE : Monday, August 19, 2019
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger by Lee Han-soo 2019-08-07 16:22
Lilly’s anticancer combo drug nears getting insurance benefit by Kim Yun-mi 2019-08-07 15:44
Lilly reports improved survival for Verzenio in P3 trial by Lee Han-soo 2019-08-07 12:06
ISU Abxis to unveil p1 results for anticancer treatment in Europe by Lee Han-soo 2019-08-07 12:03
Crystal Genomics signs accord with CRO firm by Lee Han-soo 2019-08-06 17:20
Japanese firms fear boycott may hurt prescription drug sales by Kim Yun-mi 2019-08-06 15:44
Sillajen cites salvation therapy as reason for trial suspension advice by Lee Han-soo 2019-08-06 15:43
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday' by Lee Han-soo 2019-08-06 13:50
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment by Lee Han-soo 2019-08-05 17:02
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen by Lee Han-soo 2019-08-05 16:01
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales by Kim Yun-mi 2019-08-05 15:37
Helixmith unveils results for neuromuscular disease treatment by Lee Han-soo 2019-08-02 17:52
‘MSD Korea playing tricks to maintain monitoring on salespersons’ by Kim Yun-mi 2019-08-02 15:48
Conflict erupts between employees of Takeda, Shire during merger by Kim Yun-mi 2019-08-02 14:23
Sillajen likely to scrap global P3 trials for Pexa-Vec by Lee Han-soo 2019-08-02 10:29
KAIST-Hanyang University team presents new anticancer principle by Lee Han-soo 2019-08-01 17:30
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia by Lee Han-soo 2019-08-01 13:36
New weight loss drug Qsymia wins local approval by Lee Hye-seon 2019-08-01 10:57
‘Hanmi’s Carnitil improves cognitive function in patients’ by Lee Han-soo 2019-07-31 17:05
Hanall marks record sales in Q2 by Lee Han-soo 2019-07-31 17:00
Back to Top